Delayed Diagnosis of Danon Disease in Patients Presenting With Isolated Cardiomyopathy
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Circulation. Genomic and precision medicine - 12(2019), 3 vom: 10. März, Seite e002395 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Demirdas, Serwet [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 03.06.2020 Date Revised 03.06.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.1161/CIRCGEN.118.002395 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM295419121 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM295419121 | ||
003 | DE-627 | ||
005 | 20231225083621.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1161/CIRCGEN.118.002395 |2 doi | |
028 | 5 | 2 | |a pubmed24n0984.xml |
035 | |a (DE-627)NLM295419121 | ||
035 | |a (NLM)30919683 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Demirdas, Serwet |e verfasserin |4 aut | |
245 | 1 | 0 | |a Delayed Diagnosis of Danon Disease in Patients Presenting With Isolated Cardiomyopathy |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.06.2020 | ||
500 | |a Date Revised 03.06.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Letter | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a biological variation, population | |
650 | 4 | |a cardiomyopathy, hypertrophic | |
650 | 4 | |a death, sudden, cardiac | |
650 | 4 | |a genetic testing | |
650 | 4 | |a glycogen storage disease type IIb | |
650 | 4 | |a lysosomal storage diseases | |
650 | 4 | |a pathology, molecular | |
650 | 7 | |a LAMP2 protein, human |2 NLM | |
650 | 7 | |a Lysosomal-Associated Membrane Protein 2 |2 NLM | |
700 | 1 | |a van Slegtenhorst, Marjon A |e verfasserin |4 aut | |
700 | 1 | |a Verdijk, Robert M |e verfasserin |4 aut | |
700 | 1 | |a Lee, Max |e verfasserin |4 aut | |
700 | 1 | |a van den Hout, Hannerieke M P |e verfasserin |4 aut | |
700 | 1 | |a Wessels, Marja W |e verfasserin |4 aut | |
700 | 1 | |a Frohn-Mulder, Ingrid M E |e verfasserin |4 aut | |
700 | 1 | |a Gardeitchik, Thatjana |e verfasserin |4 aut | |
700 | 1 | |a van der Ploeg, Ans T |e verfasserin |4 aut | |
700 | 1 | |a Schaaf, Gerben J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Circulation. Genomic and precision medicine |d 2018 |g 12(2019), 3 vom: 10. März, Seite e002395 |w (DE-627)NLM280989210 |x 2574-8300 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2019 |g number:3 |g day:10 |g month:03 |g pages:e002395 |
856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIRCGEN.118.002395 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2019 |e 3 |b 10 |c 03 |h e002395 |